McCarthy Daniel Joseph
PRESIDENT
Sale 10b5-1
- Shares
- 65,892
- Price
- $5.00
- Value
- $329,460
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•25 filings
EVH
Evolent Health, Inc.
Net sales of $329.5K over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$329,460
0 buyers · 1 sellers
12-month purchases
$38,199
1 distinct insiders
12-month sales
$329,460
1 distinct insiders
Highlighted alerts
1
1 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get EVH insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
EVH overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
42
Raw transactions
Everything returned by the filing
2
Voluntary view
P/S trades after deterministic checks
40
Administrative noise
Stored, never alerted
1
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- F
- Shares
- 2,650
- Price
- $5.74
- Footnotes
- 5
Represents restricted stock units granted to Mr. Weinberg pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting. Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029. Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Springstubb Brendan B
Director
PurchaseAlert
- Shares
- 10,000
- Price
- $3.82
- Value
- $38,199
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.